nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ABCB1—kidney cancer	0.11	1	CbGaD
Lovastatin—UGT1A1—Pazopanib—kidney cancer	0.0414	0.0664	CbGbCtD
Lovastatin—CYP3A7—Temsirolimus—kidney cancer	0.032	0.0514	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.032	0.0514	CbGbCtD
Lovastatin—UGT1A1—Erlotinib—kidney cancer	0.0295	0.0474	CbGbCtD
Lovastatin—SLCO1B1—Pazopanib—kidney cancer	0.0287	0.046	CbGbCtD
Lovastatin—UGT1A1—Sorafenib—kidney cancer	0.024	0.0385	CbGbCtD
Lovastatin—CYP3A5—Temsirolimus—kidney cancer	0.024	0.0385	CbGbCtD
Lovastatin—ABCC2—Paclitaxel—kidney cancer	0.0165	0.0264	CbGbCtD
Lovastatin—ABCB1—Temsirolimus—kidney cancer	0.0156	0.0251	CbGbCtD
Lovastatin—CYP2D6—Temsirolimus—kidney cancer	0.0147	0.0236	CbGbCtD
Lovastatin—ABCC2—Sorafenib—kidney cancer	0.0146	0.0235	CbGbCtD
Lovastatin—ABCC2—Vinblastine—kidney cancer	0.0144	0.0232	CbGbCtD
Lovastatin—ABCC2—Vincristine—kidney cancer	0.0142	0.0228	CbGbCtD
Lovastatin—CYP3A4—Everolimus—kidney cancer	0.0139	0.0222	CbGbCtD
Lovastatin—CYP2C8—Pazopanib—kidney cancer	0.0121	0.0195	CbGbCtD
Lovastatin—ABCC2—Sunitinib—kidney cancer	0.0118	0.019	CbGbCtD
Lovastatin—CYP3A7—Paclitaxel—kidney cancer	0.011	0.0176	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.011	0.0176	CbGbCtD
Lovastatin—CYP3A7—Sorafenib—kidney cancer	0.00976	0.0157	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00976	0.0157	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00948	0.0152	CbGbCtD
Lovastatin—CYP3A7—Vincristine—kidney cancer	0.00948	0.0152	CbGbCtD
Lovastatin—CYP3A4—Temsirolimus—kidney cancer	0.00937	0.015	CbGbCtD
Lovastatin—CYP3A5—Erlotinib—kidney cancer	0.009	0.0144	CbGbCtD
Lovastatin—ABCC2—Doxorubicin—kidney cancer	0.00887	0.0142	CbGbCtD
Lovastatin—CYP2C9—Capecitabine—kidney cancer	0.00883	0.0142	CbGbCtD
Lovastatin—CYP2C8—Erlotinib—kidney cancer	0.00866	0.0139	CbGbCtD
Lovastatin—CYP3A5—Paclitaxel—kidney cancer	0.00824	0.0132	CbGbCtD
Lovastatin—ABCB1—Pazopanib—kidney cancer	0.00821	0.0132	CbGbCtD
Lovastatin—CYP2C8—Paclitaxel—kidney cancer	0.00793	0.0127	CbGbCtD
Lovastatin—CYP3A7—Sunitinib—kidney cancer	0.00791	0.0127	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00791	0.0127	CbGbCtD
Lovastatin—CYP2D6—Pazopanib—kidney cancer	0.00774	0.0124	CbGbCtD
Lovastatin—ABCB1—Dactinomycin—kidney cancer	0.00751	0.0121	CbGbCtD
Lovastatin—CYP3A5—Sorafenib—kidney cancer	0.00732	0.0117	CbGbCtD
Lovastatin—CYP3A5—Vincristine—kidney cancer	0.00711	0.0114	CbGbCtD
Lovastatin—CYP2C8—Sorafenib—kidney cancer	0.00704	0.0113	CbGbCtD
Lovastatin—ABCB1—Gemcitabine—kidney cancer	0.00594	0.00953	CbGbCtD
Lovastatin—CYP3A5—Sunitinib—kidney cancer	0.00593	0.00952	CbGbCtD
Lovastatin—CYP2C19—Sorafenib—kidney cancer	0.00591	0.00947	CbGbCtD
Lovastatin—ABCB1—Erlotinib—kidney cancer	0.00586	0.0094	CbGbCtD
Lovastatin—CYP2C9—Paclitaxel—kidney cancer	0.00553	0.00887	CbGbCtD
Lovastatin—CYP2D6—Erlotinib—kidney cancer	0.00552	0.00886	CbGbCtD
Lovastatin—ABCB1—Paclitaxel—kidney cancer	0.00536	0.00861	CbGbCtD
Lovastatin—CYP3A4—Pazopanib—kidney cancer	0.00492	0.00789	CbGbCtD
Lovastatin—CYP2C9—Sorafenib—kidney cancer	0.00491	0.00788	CbGbCtD
Lovastatin—ABCB1—Sorafenib—kidney cancer	0.00476	0.00764	CbGbCtD
Lovastatin—ABCB1—Vinblastine—kidney cancer	0.00471	0.00755	CbGbCtD
Lovastatin—ABCB1—Vincristine—kidney cancer	0.00463	0.00742	CbGbCtD
Lovastatin—CYP2D6—Sorafenib—kidney cancer	0.00449	0.0072	CbGbCtD
Lovastatin—CYP2D6—Vinblastine—kidney cancer	0.00443	0.00711	CbGbCtD
Lovastatin—UGT1A1—urine—kidney cancer	0.00437	0.11	CbGeAlD
Lovastatin—ABCB1—Sunitinib—kidney cancer	0.00386	0.00619	CbGbCtD
Lovastatin—CYP3A4—Erlotinib—kidney cancer	0.00351	0.00563	CbGbCtD
Lovastatin—CYP3A4—Paclitaxel—kidney cancer	0.00321	0.00516	CbGbCtD
Lovastatin—ABCB1—Doxorubicin—kidney cancer	0.00289	0.00464	CbGbCtD
Lovastatin—CYP3A4—Sorafenib—kidney cancer	0.00285	0.00458	CbGbCtD
Lovastatin—CYP3A4—Vinblastine—kidney cancer	0.00282	0.00452	CbGbCtD
Lovastatin—CYP3A4—Vincristine—kidney cancer	0.00277	0.00445	CbGbCtD
Lovastatin—CYP2D6—Doxorubicin—kidney cancer	0.00272	0.00437	CbGbCtD
Lovastatin—CYP2C19—urine—kidney cancer	0.00237	0.0594	CbGeAlD
Lovastatin—CYP3A4—Sunitinib—kidney cancer	0.00231	0.00371	CbGbCtD
Lovastatin—CYP2C9—urine—kidney cancer	0.00184	0.0461	CbGeAlD
Lovastatin—CYP3A4—Doxorubicin—kidney cancer	0.00173	0.00278	CbGbCtD
Lovastatin—CYP3A4—urine—kidney cancer	0.0014	0.0351	CbGeAlD
Lovastatin—CYP2D6—urine—kidney cancer	0.00138	0.0346	CbGeAlD
Lovastatin—UGT2B7—renal system—kidney cancer	0.00126	0.0316	CbGeAlD
Lovastatin—UGT2B7—kidney—kidney cancer	0.00122	0.0305	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00121	0.0305	CbGeAlD
Lovastatin—HDAC2—nephron tubule—kidney cancer	0.00113	0.0284	CbGeAlD
Lovastatin—UGT1A1—renal system—kidney cancer	0.00107	0.0268	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.00104	0.0261	CbGeAlD
Lovastatin—UGT1A1—kidney—kidney cancer	0.00103	0.0259	CbGeAlD
Lovastatin—HDAC2—renal system—kidney cancer	0.00103	0.0258	CbGeAlD
Lovastatin—HMGCR—nephron tubule—kidney cancer	0.00102	0.0256	CbGeAlD
Lovastatin—HDAC2—kidney—kidney cancer	0.000995	0.025	CbGeAlD
Lovastatin—HDAC2—cortex of kidney—kidney cancer	0.000969	0.0243	CbGeAlD
Lovastatin—HMGCR—renal system—kidney cancer	0.000929	0.0233	CbGeAlD
Lovastatin—HDAC2—gonad—kidney cancer	0.000923	0.0232	CbGeAlD
Lovastatin—HMGCR—kidney—kidney cancer	0.000898	0.0225	CbGeAlD
Lovastatin—SLCO1B1—renal system—kidney cancer	0.00089	0.0223	CbGeAlD
Lovastatin—HMGCR—cortex of kidney—kidney cancer	0.000874	0.0219	CbGeAlD
Lovastatin—SLCO1B1—kidney—kidney cancer	0.00086	0.0216	CbGeAlD
Lovastatin—HMGCR—gonad—kidney cancer	0.000833	0.0209	CbGeAlD
Lovastatin—HMGCR—cardiac atrium—kidney cancer	0.000832	0.0209	CbGeAlD
Lovastatin—ABCC2—nephron tubule—kidney cancer	0.000742	0.0186	CbGeAlD
Lovastatin—SLCO1A2—renal system—kidney cancer	0.000724	0.0182	CbGeAlD
Lovastatin—SLCO1A2—kidney—kidney cancer	0.0007	0.0176	CbGeAlD
Lovastatin—HDAC2—Sirolimus—Everolimus—kidney cancer	0.000695	0.2	CbGdCrCtD
Lovastatin—HDAC2—Everolimus—Temsirolimus—kidney cancer	0.000695	0.2	CbGdCrCtD
Lovastatin—HDAC2—Temsirolimus—Everolimus—kidney cancer	0.000695	0.2	CbGdCrCtD
Lovastatin—HDAC2—Sirolimus—Temsirolimus—kidney cancer	0.000695	0.2	CbGdCrCtD
Lovastatin—HDAC2—Gefitinib—Erlotinib—kidney cancer	0.000693	0.2	CbGdCrCtD
Lovastatin—ABCC2—renal system—kidney cancer	0.000674	0.0169	CbGeAlD
Lovastatin—ABCC2—kidney—kidney cancer	0.000652	0.0164	CbGeAlD
Lovastatin—ABCC2—cortex of kidney—kidney cancer	0.000635	0.0159	CbGeAlD
Lovastatin—CYP2C8—renal system—kidney cancer	0.000506	0.0127	CbGeAlD
Lovastatin—CYP3A5—nephron tubule—kidney cancer	0.000502	0.0126	CbGeAlD
Lovastatin—CYP2C8—kidney—kidney cancer	0.000489	0.0123	CbGeAlD
Lovastatin—CYP3A5—renal system—kidney cancer	0.000457	0.0115	CbGeAlD
Lovastatin—CYP3A5—kidney—kidney cancer	0.000441	0.0111	CbGeAlD
Lovastatin—CYP3A5—cortex of kidney—kidney cancer	0.00043	0.0108	CbGeAlD
Lovastatin—Simvastatin—ABCB1—kidney cancer	0.000407	0.505	CrCbGaD
Lovastatin—Pravastatin—ABCB1—kidney cancer	0.000399	0.495	CrCbGaD
Lovastatin—CYP3A4—renal system—kidney cancer	0.000343	0.0086	CbGeAlD
Lovastatin—CYP2D6—renal system—kidney cancer	0.000337	0.00846	CbGeAlD
Lovastatin—CYP3A4—kidney—kidney cancer	0.000331	0.00831	CbGeAlD
Lovastatin—CYP2D6—kidney—kidney cancer	0.000326	0.00818	CbGeAlD
Lovastatin—ABCB1—nephron tubule—kidney cancer	0.000267	0.0067	CbGeAlD
Lovastatin—ABCB1—renal system—kidney cancer	0.000243	0.00609	CbGeAlD
Lovastatin—ABCB1—kidney—kidney cancer	0.000234	0.00588	CbGeAlD
Lovastatin—ABCB1—cortex of kidney—kidney cancer	0.000228	0.00573	CbGeAlD
Lovastatin—ABCB1—gonad—kidney cancer	0.000217	0.00546	CbGeAlD
Lovastatin—Fatigue—Dactinomycin—kidney cancer	0.000144	0.00104	CcSEcCtD
Lovastatin—Flatulence—Paclitaxel—kidney cancer	0.000143	0.00104	CcSEcCtD
Lovastatin—Pain—Dactinomycin—kidney cancer	0.000142	0.00103	CcSEcCtD
Lovastatin—Vascular purpura—Doxorubicin—kidney cancer	0.000142	0.00103	CcSEcCtD
Lovastatin—Anorexia—Vincristine—kidney cancer	0.000142	0.00103	CcSEcCtD
Lovastatin—Dysgeusia—Paclitaxel—kidney cancer	0.000142	0.00103	CcSEcCtD
Lovastatin—Hepatic failure—Doxorubicin—kidney cancer	0.000142	0.00103	CcSEcCtD
Lovastatin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000141	0.00102	CcSEcCtD
Lovastatin—Infection—Gemcitabine—kidney cancer	0.00014	0.00102	CcSEcCtD
Lovastatin—Back pain—Paclitaxel—kidney cancer	0.00014	0.00102	CcSEcCtD
Lovastatin—Dizziness—Vinblastine—kidney cancer	0.00014	0.00101	CcSEcCtD
Lovastatin—Dizziness—Everolimus—kidney cancer	0.000139	0.00101	CcSEcCtD
Lovastatin—Muscle spasms—Paclitaxel—kidney cancer	0.000139	0.00101	CcSEcCtD
Lovastatin—Abdominal pain—Sunitinib—kidney cancer	0.000139	0.00101	CcSEcCtD
Lovastatin—Body temperature increased—Sunitinib—kidney cancer	0.000139	0.00101	CcSEcCtD
Lovastatin—Diarrhoea—Erlotinib—kidney cancer	0.000139	0.00101	CcSEcCtD
Lovastatin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000138	0.001	CcSEcCtD
Lovastatin—Feeling abnormal—Dactinomycin—kidney cancer	0.000137	0.000996	CcSEcCtD
Lovastatin—Hepatitis—Capecitabine—kidney cancer	0.000136	0.00099	CcSEcCtD
Lovastatin—Vision blurred—Paclitaxel—kidney cancer	0.000136	0.00099	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000136	0.000988	CcSEcCtD
Lovastatin—Tremor—Paclitaxel—kidney cancer	0.000136	0.000984	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000136	0.000983	CcSEcCtD
Lovastatin—Hypersensitivity—Sorafenib—kidney cancer	0.000135	0.000977	CcSEcCtD
Lovastatin—Insomnia—Vincristine—kidney cancer	0.000135	0.000976	CcSEcCtD
Lovastatin—Anorexia—Gemcitabine—kidney cancer	0.000135	0.000976	CcSEcCtD
Lovastatin—Vomiting—Vinblastine—kidney cancer	0.000134	0.000975	CcSEcCtD
Lovastatin—Dizziness—Erlotinib—kidney cancer	0.000134	0.000975	CcSEcCtD
Lovastatin—Ill-defined disorder—Paclitaxel—kidney cancer	0.000134	0.000975	CcSEcCtD
Lovastatin—Vomiting—Everolimus—kidney cancer	0.000134	0.000971	CcSEcCtD
Lovastatin—Paraesthesia—Vincristine—kidney cancer	0.000134	0.000969	CcSEcCtD
Lovastatin—Rash—Everolimus—kidney cancer	0.000133	0.000963	CcSEcCtD
Lovastatin—Dermatitis—Everolimus—kidney cancer	0.000133	0.000962	CcSEcCtD
Lovastatin—Headache—Vinblastine—kidney cancer	0.000132	0.000961	CcSEcCtD
Lovastatin—Angioedema—Paclitaxel—kidney cancer	0.000132	0.00096	CcSEcCtD
Lovastatin—Purpura—Doxorubicin—kidney cancer	0.000132	0.000957	CcSEcCtD
Lovastatin—Headache—Everolimus—kidney cancer	0.000132	0.000957	CcSEcCtD
Lovastatin—Body temperature increased—Dactinomycin—kidney cancer	0.000132	0.000955	CcSEcCtD
Lovastatin—Abdominal pain—Dactinomycin—kidney cancer	0.000132	0.000955	CcSEcCtD
Lovastatin—Asthenia—Sorafenib—kidney cancer	0.000131	0.000952	CcSEcCtD
Lovastatin—Malaise—Paclitaxel—kidney cancer	0.000131	0.000947	CcSEcCtD
Lovastatin—Vertigo—Paclitaxel—kidney cancer	0.00013	0.000944	CcSEcCtD
Lovastatin—Leukopenia—Paclitaxel—kidney cancer	0.00013	0.00094	CcSEcCtD
Lovastatin—Hypersensitivity—Sunitinib—kidney cancer	0.00013	0.00094	CcSEcCtD
Lovastatin—Decreased appetite—Vincristine—kidney cancer	0.000129	0.000938	CcSEcCtD
Lovastatin—Pruritus—Sorafenib—kidney cancer	0.000129	0.000938	CcSEcCtD
Lovastatin—Vomiting—Erlotinib—kidney cancer	0.000129	0.000937	CcSEcCtD
Lovastatin—Erythema multiforme—Capecitabine—kidney cancer	0.000129	0.000936	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000129	0.000933	CcSEcCtD
Lovastatin—Fatigue—Vincristine—kidney cancer	0.000128	0.000931	CcSEcCtD
Lovastatin—Rash—Erlotinib—kidney cancer	0.000128	0.00093	CcSEcCtD
Lovastatin—Dermatitis—Erlotinib—kidney cancer	0.000128	0.000929	CcSEcCtD
Lovastatin—Insomnia—Gemcitabine—kidney cancer	0.000128	0.000926	CcSEcCtD
Lovastatin—Headache—Erlotinib—kidney cancer	0.000127	0.000924	CcSEcCtD
Lovastatin—Pain—Vincristine—kidney cancer	0.000127	0.000923	CcSEcCtD
Lovastatin—Constipation—Vincristine—kidney cancer	0.000127	0.000923	CcSEcCtD
Lovastatin—Pain in extremity—Doxorubicin—kidney cancer	0.000127	0.000923	CcSEcCtD
Lovastatin—Paraesthesia—Gemcitabine—kidney cancer	0.000127	0.00092	CcSEcCtD
Lovastatin—Flushing—Capecitabine—kidney cancer	0.000127	0.000919	CcSEcCtD
Lovastatin—Asthenia—Sunitinib—kidney cancer	0.000126	0.000916	CcSEcCtD
Lovastatin—Dyspnoea—Gemcitabine—kidney cancer	0.000126	0.000913	CcSEcCtD
Lovastatin—Nausea—Vinblastine—kidney cancer	0.000126	0.000911	CcSEcCtD
Lovastatin—Nausea—Everolimus—kidney cancer	0.000125	0.000908	CcSEcCtD
Lovastatin—Diarrhoea—Sorafenib—kidney cancer	0.000125	0.000907	CcSEcCtD
Lovastatin—Pruritus—Sunitinib—kidney cancer	0.000124	0.000903	CcSEcCtD
Lovastatin—Arthralgia—Paclitaxel—kidney cancer	0.000123	0.000894	CcSEcCtD
Lovastatin—Chest pain—Paclitaxel—kidney cancer	0.000123	0.000894	CcSEcCtD
Lovastatin—Myalgia—Paclitaxel—kidney cancer	0.000123	0.000894	CcSEcCtD
Lovastatin—Anxiety—Paclitaxel—kidney cancer	0.000123	0.000891	CcSEcCtD
Lovastatin—Decreased appetite—Gemcitabine—kidney cancer	0.000123	0.00089	CcSEcCtD
Lovastatin—Hypersensitivity—Dactinomycin—kidney cancer	0.000123	0.00089	CcSEcCtD
Lovastatin—Chills—Capecitabine—kidney cancer	0.000122	0.000889	CcSEcCtD
Lovastatin—Discomfort—Paclitaxel—kidney cancer	0.000122	0.000884	CcSEcCtD
Lovastatin—Fatigue—Gemcitabine—kidney cancer	0.000122	0.000883	CcSEcCtD
Lovastatin—Gastrointestinal pain—Vincristine—kidney cancer	0.000122	0.000883	CcSEcCtD
Lovastatin—Dizziness—Sorafenib—kidney cancer	0.000121	0.000877	CcSEcCtD
Lovastatin—Pain—Gemcitabine—kidney cancer	0.000121	0.000876	CcSEcCtD
Lovastatin—Constipation—Gemcitabine—kidney cancer	0.000121	0.000876	CcSEcCtD
Lovastatin—Nausea—Erlotinib—kidney cancer	0.000121	0.000876	CcSEcCtD
Lovastatin—Alopecia—Capecitabine—kidney cancer	0.000121	0.000875	CcSEcCtD
Lovastatin—Dry mouth—Paclitaxel—kidney cancer	0.000121	0.000875	CcSEcCtD
Lovastatin—Diarrhoea—Sunitinib—kidney cancer	0.00012	0.000873	CcSEcCtD
Lovastatin—Asthenia—Dactinomycin—kidney cancer	0.000119	0.000867	CcSEcCtD
Lovastatin—Confusional state—Paclitaxel—kidney cancer	0.000119	0.000864	CcSEcCtD
Lovastatin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000118	0.000857	CcSEcCtD
Lovastatin—Body temperature increased—Vincristine—kidney cancer	0.000118	0.000853	CcSEcCtD
Lovastatin—Abdominal pain—Vincristine—kidney cancer	0.000118	0.000853	CcSEcCtD
Lovastatin—Infection—Paclitaxel—kidney cancer	0.000117	0.000852	CcSEcCtD
Lovastatin—Flatulence—Capecitabine—kidney cancer	0.000117	0.000849	CcSEcCtD
Lovastatin—Dysgeusia—Capecitabine—kidney cancer	0.000116	0.000844	CcSEcCtD
Lovastatin—Dizziness—Sunitinib—kidney cancer	0.000116	0.000844	CcSEcCtD
Lovastatin—Feeling abnormal—Gemcitabine—kidney cancer	0.000116	0.000844	CcSEcCtD
Lovastatin—Vomiting—Sorafenib—kidney cancer	0.000116	0.000843	CcSEcCtD
Lovastatin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000116	0.000839	CcSEcCtD
Lovastatin—Rash—Sorafenib—kidney cancer	0.000115	0.000836	CcSEcCtD
Lovastatin—Dermatitis—Sorafenib—kidney cancer	0.000115	0.000835	CcSEcCtD
Lovastatin—Back pain—Capecitabine—kidney cancer	0.000115	0.000834	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000115	0.000831	CcSEcCtD
Lovastatin—Headache—Sorafenib—kidney cancer	0.000115	0.000831	CcSEcCtD
Lovastatin—Muscle spasms—Capecitabine—kidney cancer	0.000114	0.000829	CcSEcCtD
Lovastatin—Diarrhoea—Dactinomycin—kidney cancer	0.000114	0.000827	CcSEcCtD
Lovastatin—Anorexia—Paclitaxel—kidney cancer	0.000113	0.000817	CcSEcCtD
Lovastatin—Vision blurred—Capecitabine—kidney cancer	0.000112	0.000812	CcSEcCtD
Lovastatin—Vomiting—Sunitinib—kidney cancer	0.000112	0.000811	CcSEcCtD
Lovastatin—Body temperature increased—Gemcitabine—kidney cancer	0.000112	0.000809	CcSEcCtD
Lovastatin—Tremor—Capecitabine—kidney cancer	0.000111	0.000808	CcSEcCtD
Lovastatin—Rash—Sunitinib—kidney cancer	0.000111	0.000805	CcSEcCtD
Lovastatin—Dermatitis—Sunitinib—kidney cancer	0.000111	0.000804	CcSEcCtD
Lovastatin—Ill-defined disorder—Capecitabine—kidney cancer	0.00011	0.0008	CcSEcCtD
Lovastatin—Headache—Sunitinib—kidney cancer	0.00011	0.000799	CcSEcCtD
Lovastatin—Influenza—Doxorubicin—kidney cancer	0.00011	0.000798	CcSEcCtD
Lovastatin—Hypersensitivity—Vincristine—kidney cancer	0.00011	0.000795	CcSEcCtD
Lovastatin—Eosinophilia—Doxorubicin—kidney cancer	0.000109	0.00079	CcSEcCtD
Lovastatin—Nausea—Sorafenib—kidney cancer	0.000109	0.000788	CcSEcCtD
Lovastatin—Pancreatitis—Doxorubicin—kidney cancer	0.000108	0.000782	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000108	0.000781	CcSEcCtD
Lovastatin—Malaise—Capecitabine—kidney cancer	0.000107	0.000777	CcSEcCtD
Lovastatin—Insomnia—Paclitaxel—kidney cancer	0.000107	0.000775	CcSEcCtD
Lovastatin—Vertigo—Capecitabine—kidney cancer	0.000107	0.000775	CcSEcCtD
Lovastatin—Asthenia—Vincristine—kidney cancer	0.000107	0.000774	CcSEcCtD
Lovastatin—Leukopenia—Capecitabine—kidney cancer	0.000106	0.000772	CcSEcCtD
Lovastatin—Paraesthesia—Paclitaxel—kidney cancer	0.000106	0.00077	CcSEcCtD
Lovastatin—Vomiting—Dactinomycin—kidney cancer	0.000106	0.000768	CcSEcCtD
Lovastatin—Dyspnoea—Paclitaxel—kidney cancer	0.000105	0.000764	CcSEcCtD
Lovastatin—Rash—Dactinomycin—kidney cancer	0.000105	0.000762	CcSEcCtD
Lovastatin—Nausea—Sunitinib—kidney cancer	0.000104	0.000758	CcSEcCtD
Lovastatin—Dyspepsia—Paclitaxel—kidney cancer	0.000104	0.000755	CcSEcCtD
Lovastatin—Decreased appetite—Paclitaxel—kidney cancer	0.000103	0.000745	CcSEcCtD
Lovastatin—Fatigue—Paclitaxel—kidney cancer	0.000102	0.000739	CcSEcCtD
Lovastatin—Diarrhoea—Vincristine—kidney cancer	0.000102	0.000739	CcSEcCtD
Lovastatin—Asthenia—Gemcitabine—kidney cancer	0.000101	0.000735	CcSEcCtD
Lovastatin—Myalgia—Capecitabine—kidney cancer	0.000101	0.000734	CcSEcCtD
Lovastatin—Chest pain—Capecitabine—kidney cancer	0.000101	0.000734	CcSEcCtD
Lovastatin—Arthralgia—Capecitabine—kidney cancer	0.000101	0.000734	CcSEcCtD
Lovastatin—Pain—Paclitaxel—kidney cancer	0.000101	0.000733	CcSEcCtD
Lovastatin—Constipation—Paclitaxel—kidney cancer	0.000101	0.000733	CcSEcCtD
Lovastatin—Anxiety—Capecitabine—kidney cancer	0.000101	0.000731	CcSEcCtD
Lovastatin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.0001	0.000728	CcSEcCtD
Lovastatin—Discomfort—Capecitabine—kidney cancer	9.99e-05	0.000725	CcSEcCtD
Lovastatin—Pruritus—Gemcitabine—kidney cancer	9.99e-05	0.000724	CcSEcCtD
Lovastatin—Dry mouth—Capecitabine—kidney cancer	9.89e-05	0.000718	CcSEcCtD
Lovastatin—Nausea—Dactinomycin—kidney cancer	9.89e-05	0.000718	CcSEcCtD
Lovastatin—Dizziness—Vincristine—kidney cancer	9.84e-05	0.000714	CcSEcCtD
Lovastatin—Confusional state—Capecitabine—kidney cancer	9.78e-05	0.000709	CcSEcCtD
Lovastatin—Feeling abnormal—Paclitaxel—kidney cancer	9.74e-05	0.000707	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	9.72e-05	0.000705	CcSEcCtD
Lovastatin—Gastrointestinal pain—Paclitaxel—kidney cancer	9.66e-05	0.000701	CcSEcCtD
Lovastatin—Diarrhoea—Gemcitabine—kidney cancer	9.66e-05	0.000701	CcSEcCtD
Lovastatin—Infection—Capecitabine—kidney cancer	9.63e-05	0.000699	CcSEcCtD
Lovastatin—Neuropathy peripheral—Doxorubicin—kidney cancer	9.61e-05	0.000697	CcSEcCtD
Lovastatin—Urinary tract infection—Doxorubicin—kidney cancer	9.53e-05	0.000691	CcSEcCtD
Lovastatin—Thrombocytopenia—Capecitabine—kidney cancer	9.49e-05	0.000689	CcSEcCtD
Lovastatin—Vomiting—Vincristine—kidney cancer	9.46e-05	0.000686	CcSEcCtD
Lovastatin—Urticaria—Paclitaxel—kidney cancer	9.39e-05	0.000681	CcSEcCtD
Lovastatin—Rash—Vincristine—kidney cancer	9.38e-05	0.000681	CcSEcCtD
Lovastatin—Dermatitis—Vincristine—kidney cancer	9.37e-05	0.00068	CcSEcCtD
Lovastatin—Body temperature increased—Paclitaxel—kidney cancer	9.34e-05	0.000678	CcSEcCtD
Lovastatin—Abdominal pain—Paclitaxel—kidney cancer	9.34e-05	0.000678	CcSEcCtD
Lovastatin—Headache—Vincristine—kidney cancer	9.32e-05	0.000676	CcSEcCtD
Lovastatin—Anorexia—Capecitabine—kidney cancer	9.24e-05	0.000671	CcSEcCtD
Lovastatin—Sinusitis—Doxorubicin—kidney cancer	9.2e-05	0.000667	CcSEcCtD
Lovastatin—Vomiting—Gemcitabine—kidney cancer	8.97e-05	0.000651	CcSEcCtD
Lovastatin—Rash—Gemcitabine—kidney cancer	8.9e-05	0.000646	CcSEcCtD
Lovastatin—Dermatitis—Gemcitabine—kidney cancer	8.89e-05	0.000645	CcSEcCtD
Lovastatin—Headache—Gemcitabine—kidney cancer	8.84e-05	0.000642	CcSEcCtD
Lovastatin—Nausea—Vincristine—kidney cancer	8.84e-05	0.000641	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.84e-05	0.000641	CcSEcCtD
Lovastatin—Hepatitis—Doxorubicin—kidney cancer	8.8e-05	0.000638	CcSEcCtD
Lovastatin—Insomnia—Capecitabine—kidney cancer	8.77e-05	0.000636	CcSEcCtD
Lovastatin—Paraesthesia—Capecitabine—kidney cancer	8.71e-05	0.000632	CcSEcCtD
Lovastatin—Hypersensitivity—Paclitaxel—kidney cancer	8.71e-05	0.000632	CcSEcCtD
Lovastatin—Dyspnoea—Capecitabine—kidney cancer	8.65e-05	0.000627	CcSEcCtD
Lovastatin—Dyspepsia—Capecitabine—kidney cancer	8.54e-05	0.000619	CcSEcCtD
Lovastatin—Asthenia—Paclitaxel—kidney cancer	8.48e-05	0.000615	CcSEcCtD
Lovastatin—Decreased appetite—Capecitabine—kidney cancer	8.43e-05	0.000612	CcSEcCtD
Lovastatin—Nausea—Gemcitabine—kidney cancer	8.38e-05	0.000608	CcSEcCtD
Lovastatin—Fatigue—Capecitabine—kidney cancer	8.36e-05	0.000607	CcSEcCtD
Lovastatin—Pruritus—Paclitaxel—kidney cancer	8.36e-05	0.000607	CcSEcCtD
Lovastatin—Erythema multiforme—Doxorubicin—kidney cancer	8.32e-05	0.000604	CcSEcCtD
Lovastatin—Pain—Capecitabine—kidney cancer	8.29e-05	0.000602	CcSEcCtD
Lovastatin—Constipation—Capecitabine—kidney cancer	8.29e-05	0.000602	CcSEcCtD
Lovastatin—Flushing—Doxorubicin—kidney cancer	8.17e-05	0.000592	CcSEcCtD
Lovastatin—Diarrhoea—Paclitaxel—kidney cancer	8.09e-05	0.000587	CcSEcCtD
Lovastatin—Feeling abnormal—Capecitabine—kidney cancer	7.99e-05	0.00058	CcSEcCtD
Lovastatin—Gastrointestinal pain—Capecitabine—kidney cancer	7.93e-05	0.000575	CcSEcCtD
Lovastatin—Chills—Doxorubicin—kidney cancer	7.89e-05	0.000573	CcSEcCtD
Lovastatin—Dizziness—Paclitaxel—kidney cancer	7.81e-05	0.000567	CcSEcCtD
Lovastatin—Alopecia—Doxorubicin—kidney cancer	7.77e-05	0.000564	CcSEcCtD
Lovastatin—Urticaria—Capecitabine—kidney cancer	7.7e-05	0.000559	CcSEcCtD
Lovastatin—Body temperature increased—Capecitabine—kidney cancer	7.67e-05	0.000556	CcSEcCtD
Lovastatin—Abdominal pain—Capecitabine—kidney cancer	7.67e-05	0.000556	CcSEcCtD
Lovastatin—Flatulence—Doxorubicin—kidney cancer	7.55e-05	0.000548	CcSEcCtD
Lovastatin—Vomiting—Paclitaxel—kidney cancer	7.51e-05	0.000545	CcSEcCtD
Lovastatin—Dysgeusia—Doxorubicin—kidney cancer	7.5e-05	0.000544	CcSEcCtD
Lovastatin—Rash—Paclitaxel—kidney cancer	7.45e-05	0.000541	CcSEcCtD
Lovastatin—Dermatitis—Paclitaxel—kidney cancer	7.44e-05	0.00054	CcSEcCtD
Lovastatin—Back pain—Doxorubicin—kidney cancer	7.41e-05	0.000538	CcSEcCtD
Lovastatin—Headache—Paclitaxel—kidney cancer	7.4e-05	0.000537	CcSEcCtD
Lovastatin—Muscle spasms—Doxorubicin—kidney cancer	7.36e-05	0.000534	CcSEcCtD
Lovastatin—Vision blurred—Doxorubicin—kidney cancer	7.22e-05	0.000524	CcSEcCtD
Lovastatin—Hypersensitivity—Capecitabine—kidney cancer	7.14e-05	0.000518	CcSEcCtD
Lovastatin—Ill-defined disorder—Doxorubicin—kidney cancer	7.11e-05	0.000516	CcSEcCtD
Lovastatin—Nausea—Paclitaxel—kidney cancer	7.02e-05	0.000509	CcSEcCtD
Lovastatin—Asthenia—Capecitabine—kidney cancer	6.96e-05	0.000505	CcSEcCtD
Lovastatin—Malaise—Doxorubicin—kidney cancer	6.91e-05	0.000501	CcSEcCtD
Lovastatin—Vertigo—Doxorubicin—kidney cancer	6.88e-05	0.000499	CcSEcCtD
Lovastatin—Pruritus—Capecitabine—kidney cancer	6.86e-05	0.000498	CcSEcCtD
Lovastatin—Leukopenia—Doxorubicin—kidney cancer	6.86e-05	0.000497	CcSEcCtD
Lovastatin—Diarrhoea—Capecitabine—kidney cancer	6.64e-05	0.000481	CcSEcCtD
Lovastatin—Chest pain—Doxorubicin—kidney cancer	6.52e-05	0.000473	CcSEcCtD
Lovastatin—Arthralgia—Doxorubicin—kidney cancer	6.52e-05	0.000473	CcSEcCtD
Lovastatin—Myalgia—Doxorubicin—kidney cancer	6.52e-05	0.000473	CcSEcCtD
Lovastatin—Anxiety—Doxorubicin—kidney cancer	6.5e-05	0.000471	CcSEcCtD
Lovastatin—Discomfort—Doxorubicin—kidney cancer	6.44e-05	0.000467	CcSEcCtD
Lovastatin—Dizziness—Capecitabine—kidney cancer	6.41e-05	0.000465	CcSEcCtD
Lovastatin—Dry mouth—Doxorubicin—kidney cancer	6.38e-05	0.000463	CcSEcCtD
Lovastatin—Confusional state—Doxorubicin—kidney cancer	6.3e-05	0.000457	CcSEcCtD
Lovastatin—Anaphylactic shock—Doxorubicin—kidney cancer	6.25e-05	0.000454	CcSEcCtD
Lovastatin—Infection—Doxorubicin—kidney cancer	6.21e-05	0.000451	CcSEcCtD
Lovastatin—Vomiting—Capecitabine—kidney cancer	6.17e-05	0.000447	CcSEcCtD
Lovastatin—Thrombocytopenia—Doxorubicin—kidney cancer	6.12e-05	0.000444	CcSEcCtD
Lovastatin—Rash—Capecitabine—kidney cancer	6.11e-05	0.000444	CcSEcCtD
Lovastatin—Dermatitis—Capecitabine—kidney cancer	6.11e-05	0.000443	CcSEcCtD
Lovastatin—Headache—Capecitabine—kidney cancer	6.08e-05	0.000441	CcSEcCtD
Lovastatin—Anorexia—Doxorubicin—kidney cancer	5.96e-05	0.000432	CcSEcCtD
Lovastatin—Nausea—Capecitabine—kidney cancer	5.76e-05	0.000418	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.7e-05	0.000413	CcSEcCtD
Lovastatin—Insomnia—Doxorubicin—kidney cancer	5.65e-05	0.00041	CcSEcCtD
Lovastatin—Paraesthesia—Doxorubicin—kidney cancer	5.61e-05	0.000407	CcSEcCtD
Lovastatin—Dyspnoea—Doxorubicin—kidney cancer	5.57e-05	0.000404	CcSEcCtD
Lovastatin—Dyspepsia—Doxorubicin—kidney cancer	5.5e-05	0.000399	CcSEcCtD
Lovastatin—Decreased appetite—Doxorubicin—kidney cancer	5.43e-05	0.000394	CcSEcCtD
Lovastatin—Fatigue—Doxorubicin—kidney cancer	5.39e-05	0.000391	CcSEcCtD
Lovastatin—Pain—Doxorubicin—kidney cancer	5.35e-05	0.000388	CcSEcCtD
Lovastatin—Constipation—Doxorubicin—kidney cancer	5.35e-05	0.000388	CcSEcCtD
Lovastatin—Feeling abnormal—Doxorubicin—kidney cancer	5.15e-05	0.000374	CcSEcCtD
Lovastatin—Gastrointestinal pain—Doxorubicin—kidney cancer	5.11e-05	0.000371	CcSEcCtD
Lovastatin—Urticaria—Doxorubicin—kidney cancer	4.97e-05	0.00036	CcSEcCtD
Lovastatin—Body temperature increased—Doxorubicin—kidney cancer	4.94e-05	0.000359	CcSEcCtD
Lovastatin—Abdominal pain—Doxorubicin—kidney cancer	4.94e-05	0.000359	CcSEcCtD
Lovastatin—Hypersensitivity—Doxorubicin—kidney cancer	4.61e-05	0.000334	CcSEcCtD
Lovastatin—Asthenia—Doxorubicin—kidney cancer	4.48e-05	0.000325	CcSEcCtD
Lovastatin—Pruritus—Doxorubicin—kidney cancer	4.42e-05	0.000321	CcSEcCtD
Lovastatin—Diarrhoea—Doxorubicin—kidney cancer	4.28e-05	0.00031	CcSEcCtD
Lovastatin—Dizziness—Doxorubicin—kidney cancer	4.13e-05	0.0003	CcSEcCtD
Lovastatin—Vomiting—Doxorubicin—kidney cancer	3.97e-05	0.000288	CcSEcCtD
Lovastatin—Rash—Doxorubicin—kidney cancer	3.94e-05	0.000286	CcSEcCtD
Lovastatin—Dermatitis—Doxorubicin—kidney cancer	3.94e-05	0.000286	CcSEcCtD
Lovastatin—Headache—Doxorubicin—kidney cancer	3.92e-05	0.000284	CcSEcCtD
Lovastatin—Nausea—Doxorubicin—kidney cancer	3.71e-05	0.000269	CcSEcCtD
Lovastatin—CYP2C9—Metabolism—SLC5A3—kidney cancer	9.2e-06	0.000109	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SLC2A1—kidney cancer	9.2e-06	0.000109	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.18e-06	0.000109	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTP1—kidney cancer	9.12e-06	0.000108	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—LDHB—kidney cancer	9.1e-06	0.000108	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—LDHB—kidney cancer	9.02e-06	0.000107	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSTM1—kidney cancer	8.98e-06	0.000106	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ITPR2—kidney cancer	8.77e-06	0.000104	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	8.69e-06	0.000103	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ABCB1—kidney cancer	8.63e-06	0.000102	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CA9—kidney cancer	8.58e-06	0.000102	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—POMC—kidney cancer	8.57e-06	0.000102	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP1A1—kidney cancer	8.51e-06	0.000101	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.48e-06	0.0001	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.45e-06	0.0001	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—kidney cancer	8.39e-06	9.94e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.39e-06	9.93e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HIF1A—kidney cancer	8.38e-06	9.93e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTM1—kidney cancer	8.38e-06	9.93e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CA9—kidney cancer	8.37e-06	9.92e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TSC2—kidney cancer	8.36e-06	9.91e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTP1—kidney cancer	8.36e-06	9.9e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RAF1—kidney cancer	8.28e-06	9.81e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.26e-06	9.79e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ERBB2—kidney cancer	8.19e-06	9.7e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CRABP1—kidney cancer	8.17e-06	9.68e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MTOR—kidney cancer	8.08e-06	9.57e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD4—kidney cancer	8.07e-06	9.56e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KDR—kidney cancer	8.02e-06	9.5e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—kidney cancer	8.01e-06	9.49e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPAT—kidney cancer	8.01e-06	9.48e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.01e-06	9.48e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ACHE—kidney cancer	8e-06	9.48e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTT1—kidney cancer	8e-06	9.48e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP1A1—kidney cancer	7.95e-06	9.41e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ABCB1—kidney cancer	7.91e-06	9.37e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CA9—kidney cancer	7.89e-06	9.35e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CA9—kidney cancer	7.82e-06	9.27e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.81e-06	9.25e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTM1—kidney cancer	7.68e-06	9.1e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTP1—kidney cancer	7.67e-06	9.09e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.65e-06	9.06e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ITPR2—kidney cancer	7.6e-06	9e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CDKN1B—kidney cancer	7.58e-06	8.99e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SCARB1—kidney cancer	7.57e-06	8.97e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS1—kidney cancer	7.5e-06	8.88e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FH—kidney cancer	7.44e-06	8.82e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APRT—kidney cancer	7.44e-06	8.82e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APC—kidney cancer	7.39e-06	8.75e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KIT—kidney cancer	7.39e-06	8.75e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PSMD7—kidney cancer	7.35e-06	8.71e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTEN—kidney cancer	7.32e-06	8.67e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CRABP1—kidney cancer	7.29e-06	8.64e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—POMC—kidney cancer	7.29e-06	8.64e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP1A1—kidney cancer	7.28e-06	8.63e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ABCB1—kidney cancer	7.26e-06	8.6e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.17e-06	8.5e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CTNNB1—kidney cancer	7.17e-06	8.49e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CRABP1—kidney cancer	7.12e-06	8.44e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTM1—kidney cancer	7.05e-06	8.35e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—POMC—kidney cancer	7.03e-06	8.33e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7e-06	8.3e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPC3—kidney cancer	7e-06	8.29e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.99e-06	8.29e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTEN—kidney cancer	6.98e-06	8.27e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—BCHE—kidney cancer	6.97e-06	8.26e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—BRAF—kidney cancer	6.94e-06	8.22e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.94e-06	8.22e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTT1—kidney cancer	6.93e-06	8.21e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ACHE—kidney cancer	6.93e-06	8.21e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC5A5—kidney cancer	6.88e-06	8.15e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—kidney cancer	6.84e-06	8.1e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CA2—kidney cancer	6.81e-06	8.06e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ITPR2—kidney cancer	6.78e-06	8.03e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CRABP1—kidney cancer	6.71e-06	7.95e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP1A1—kidney cancer	6.68e-06	7.92e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CRABP1—kidney cancer	6.65e-06	7.88e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC2A1—kidney cancer	6.65e-06	7.88e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALAD—kidney cancer	6.63e-06	7.86e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ITPR2—kidney cancer	6.62e-06	7.84e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SCARB1—kidney cancer	6.56e-06	7.77e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS1—kidney cancer	6.49e-06	7.69e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.48e-06	7.67e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MAPK3—kidney cancer	6.43e-06	7.61e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PSMD7—kidney cancer	6.37e-06	7.54e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—POMC—kidney cancer	6.35e-06	7.52e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.33e-06	7.5e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.25e-06	7.41e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—kidney cancer	6.25e-06	7.41e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ITPR2—kidney cancer	6.24e-06	7.39e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ACHE—kidney cancer	6.18e-06	7.33e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTT1—kidney cancer	6.18e-06	7.33e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ITPR2—kidney cancer	6.18e-06	7.33e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.07e-06	7.19e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PGK1—kidney cancer	6.07e-06	7.19e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ACHE—kidney cancer	6.04e-06	7.15e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTT1—kidney cancer	6.04e-06	7.15e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—BCHE—kidney cancer	6.04e-06	7.15e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.98e-06	7.09e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK3—kidney cancer	5.97e-06	7.07e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTEN—kidney cancer	5.96e-06	7.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC5A5—kidney cancer	5.96e-06	7.06e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LDHB—kidney cancer	5.95e-06	7.05e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—POMC—kidney cancer	5.92e-06	7.02e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SCARB1—kidney cancer	5.85e-06	6.94e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—kidney cancer	5.81e-06	6.89e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—kidney cancer	5.8e-06	6.88e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RAF1—kidney cancer	5.8e-06	6.87e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS1—kidney cancer	5.8e-06	6.87e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RELA—kidney cancer	5.77e-06	6.84e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC2A1—kidney cancer	5.76e-06	6.82e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB2—kidney cancer	5.74e-06	6.79e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SCARB1—kidney cancer	5.71e-06	6.77e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.7e-06	6.75e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ACHE—kidney cancer	5.69e-06	6.74e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTT1—kidney cancer	5.69e-06	6.74e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PSMD7—kidney cancer	5.68e-06	6.73e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK1—kidney cancer	5.68e-06	6.73e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MTOR—kidney cancer	5.66e-06	6.7e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS1—kidney cancer	5.66e-06	6.7e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTT1—kidney cancer	5.64e-06	6.68e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ACHE—kidney cancer	5.64e-06	6.68e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.59e-06	6.62e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PSMD7—kidney cancer	5.55e-06	6.57e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTP1—kidney cancer	5.54e-06	6.57e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—POMC—kidney cancer	5.43e-06	6.43e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—BCHE—kidney cancer	5.39e-06	6.38e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SCARB1—kidney cancer	5.38e-06	6.38e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KRAS—kidney cancer	5.36e-06	6.35e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SCARB1—kidney cancer	5.34e-06	6.32e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS1—kidney cancer	5.33e-06	6.31e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC5A5—kidney cancer	5.32e-06	6.3e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1B—kidney cancer	5.31e-06	6.29e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS1—kidney cancer	5.28e-06	6.26e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—BCHE—kidney cancer	5.26e-06	6.23e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCB1—kidney cancer	5.25e-06	6.22e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PSMD7—kidney cancer	5.23e-06	6.19e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—kidney cancer	5.2e-06	6.16e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC5A5—kidney cancer	5.19e-06	6.15e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PSMD7—kidney cancer	5.18e-06	6.14e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—kidney cancer	5.16e-06	6.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CA9—kidney cancer	5.16e-06	6.11e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC2A1—kidney cancer	5.14e-06	6.09e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTM1—kidney cancer	5.1e-06	6.04e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTEN—kidney cancer	5.07e-06	6.01e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—kidney cancer	5.07e-06	6e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—kidney cancer	5.06e-06	6e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—JUN—kidney cancer	5.06e-06	5.99e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CTNNB1—kidney cancer	5.02e-06	5.94e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC2A1—kidney cancer	5.02e-06	5.94e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.99e-06	5.91e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—POMC—kidney cancer	4.98e-06	5.9e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—BCHE—kidney cancer	4.96e-06	5.87e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—kidney cancer	4.93e-06	5.84e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—BCHE—kidney cancer	4.91e-06	5.82e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.89e-06	5.8e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTEN—kidney cancer	4.89e-06	5.79e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.87e-06	5.77e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.85e-06	5.75e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.83e-06	5.72e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTP1—kidney cancer	4.8e-06	5.69e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.78e-06	5.67e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.73e-06	5.6e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—kidney cancer	4.73e-06	5.6e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.69e-06	5.55e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.55e-06	5.39e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB1—kidney cancer	4.55e-06	5.39e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—kidney cancer	4.42e-06	5.23e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—kidney cancer	4.42e-06	5.23e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTM1—kidney cancer	4.41e-06	5.23e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CRABP1—kidney cancer	4.39e-06	5.2e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.35e-06	5.15e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—kidney cancer	4.33e-06	5.13e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTP1—kidney cancer	4.29e-06	5.08e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—kidney cancer	4.21e-06	4.98e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTP1—kidney cancer	4.18e-06	4.96e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP1A1—kidney cancer	4.18e-06	4.96e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK3—kidney cancer	4.18e-06	4.95e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—kidney cancer	4.12e-06	4.88e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ITPR2—kidney cancer	4.08e-06	4.83e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—kidney cancer	4.06e-06	4.81e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB1—kidney cancer	4.06e-06	4.81e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK1—kidney cancer	3.98e-06	4.71e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—kidney cancer	3.97e-06	4.71e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.97e-06	4.7e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTP1—kidney cancer	3.94e-06	4.67e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTM1—kidney cancer	3.94e-06	4.67e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTP1—kidney cancer	3.91e-06	4.63e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTM1—kidney cancer	3.84e-06	4.55e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—kidney cancer	3.78e-06	4.47e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—kidney cancer	3.76e-06	4.45e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.73e-06	4.42e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB1—kidney cancer	3.73e-06	4.42e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTT1—kidney cancer	3.72e-06	4.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ACHE—kidney cancer	3.72e-06	4.41e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB1—kidney cancer	3.7e-06	4.38e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP1A1—kidney cancer	3.64e-06	4.32e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTM1—kidney cancer	3.62e-06	4.29e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—POMC—kidney cancer	3.6e-06	4.27e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTM1—kidney cancer	3.59e-06	4.26e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—kidney cancer	3.58e-06	4.24e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SCARB1—kidney cancer	3.52e-06	4.17e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS1—kidney cancer	3.48e-06	4.13e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—kidney cancer	3.47e-06	4.11e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—kidney cancer	3.45e-06	4.09e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.44e-06	4.07e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.43e-06	4.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PSMD7—kidney cancer	3.42e-06	4.05e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.41e-06	4.03e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—kidney cancer	3.34e-06	3.95e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BCHE—kidney cancer	3.24e-06	3.84e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.2e-06	3.79e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—POMC—kidney cancer	3.12e-06	3.7e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—kidney cancer	3.12e-06	3.69e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.09e-06	3.66e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.07e-06	3.63e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—kidney cancer	2.91e-06	3.44e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—kidney cancer	2.87e-06	3.4e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.8e-06	3.31e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—POMC—kidney cancer	2.78e-06	3.3e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—POMC—kidney cancer	2.72e-06	3.22e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—kidney cancer	2.66e-06	3.16e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTP1—kidney cancer	2.58e-06	3.05e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—POMC—kidney cancer	2.56e-06	3.03e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—POMC—kidney cancer	2.54e-06	3.01e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—kidney cancer	2.51e-06	2.97e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—kidney cancer	2.49e-06	2.95e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.44e-06	2.9e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB1—kidney cancer	2.44e-06	2.89e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTM1—kidney cancer	2.37e-06	2.81e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.25e-06	2.66e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—kidney cancer	2.22e-06	2.63e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—kidney cancer	2.17e-06	2.57e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—kidney cancer	2.17e-06	2.57e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—kidney cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—kidney cancer	2.02e-06	2.4e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—kidney cancer	1.94e-06	2.29e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—kidney cancer	1.89e-06	2.24e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—kidney cancer	1.78e-06	2.11e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.77e-06	2.09e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—kidney cancer	1.77e-06	2.09e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—POMC—kidney cancer	1.67e-06	1.98e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.53e-06	1.81e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.37e-06	1.62e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—kidney cancer	1.34e-06	1.58e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—kidney cancer	1.33e-06	1.58e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.26e-06	1.49e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.25e-06	1.48e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—kidney cancer	1.16e-06	1.38e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.22e-07	9.73e-06	CbGpPWpGaD
